SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-008797
Filing Date
2020-03-05
Accepted
2020-03-05 07:02:24
Documents
3
Period of Report
2020-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-8k_20200305.htm 8-K 31422
2 EX-99.1 eypt-ex991_6.htm EX-99.1 334450
3 GRAPHIC ggemy2xc1v0e000001.jpg GRAPHIC 5170
  Complete submission text file 0001564590-20-008797.txt   374482
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 20689610
SIC: 3826 Laboratory Analytical Instruments
Office of Life Sciences